Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.32
Delayed Data
As of Jul 27
 -0.01 / -3.03%
Today’s Change
0.27
Today|||52-Week Range
0.89
-11.69%
Year-to-Date
No recent news for Mateon Therapeutics Inc.

Today’s Trading

Previous close0.33
Today’s open0.31
Day’s range0.31 - 0.33
Volume18,776
Average volume (3 months)73,229
Market cap$8.5M
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)+5.56%
Earnings growth (this year)+8.82%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.68

Competitors

No competitors data available.

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$13.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
William D. Schwieterman
Chief Financial Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts

Chart unavailable